The Prolistem treatment has emerged as a breakthrough for men grappling with non-obstructive azoospermia, a condition that can be incredibly challenging to address. Its efficacy and safety have been rigorously assessed and endorsed by the Turkish Urology Association, elevating it to the esteemed status of the gold standard in pre-microTESE care. This approval signifies not only its effectiveness in addressing the root causes of azoospermia but also its potential to enhance the success rates of subsequent microTESE procedures. With Prolistem paving the way as a trusted intervention, hope shines brighter for individuals navigating the complexities of male infertility.
The article: https://www.uroturk.org.tr/urolojiData/Books/991/prolistem-in-non-obstruktif-azospermide-klinik-kullanimi.pdf
Introduction Is Prolistem effective for azoospermia? This question is vital for many men struggling with infertility due to azoospermia — a condition characterized by the
Prolistem for non-obstructive azoospermia is gaining attention in the world of male fertility treatment. For men diagnosed with NOA—a condition where the body fails to
Prolistem, a patented formula, has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
PROLISTEM® is a Patented Formula
Copyright © 2025 Prolistem®
